HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma

Clinical trial NCT05290116 · UNKNOWN

Trial details

NCT number: NCT05290116
Sponsor: Yunfei Yuan
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Intrahepatic Cholangiocarcinoma

Start date: 2022-07-21
Primary completion: 2023-05-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.